. DE
Fe ArthroCare C27 2005
AS Corporation . .
= Ko73 4¢7
510(k) Summary
é
ArthroCare Corporation (age ( 4}. @
ArthroCare® PercD” SpineWand c

General Information
Submitter Name/Address: ArthroCare Corporation

680 Vaqueros Avenue

Sunnyvale, CA 94085-2936
Establishment Registration Number: 2951580
Contact Person: Valerie Defiesta-Ng

Director, Regulatory Affairs
Date Prepared: December 9, 2005
Device Description
Trade Name: ArthroCare" Perc)” SpineWand™
Generic/Common Name: Electrosurgical Device and Accessories
Classification Name: Electrosurgical Cutting and Coagulation

Device and Accessories (21 CFR

878.4400)
Predicate Devices
ArthroCare PereD SpineWand K030954
Product_Description
The Wands arc bipolar, single use, high frequency clectrosurgical devices.
Intended Use
The Pere-D™ SpineWand"” is indicated for ablation, coagulation, and decompression of
disc material to treat symptomatic patients with contained herniated discs.
Substantial Equivalence
This Special 5 10(k) proposes modifications in materials for the ArthroCare PereD
SpineWand, which were previously cleared under K030934 on April 16, 2003. The
indications for use, technology. principle of operation, performance specifications,
packaging, and sterilization parameters of the SpineWands remain the same as in the
predicate cleared 3 10(k)

xi

KOoF3 oe
— Lo
Summary of Safety and Effectiveness FA fe
The modified SpineWands, as described in this submission, are substantially equivalent
to the predicate SpineWands. The proposed modification in materials are not substantial
changes or modifications, and do not significantly affect the safety or efficacy of the
devices.
Xi

f 4 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
wok Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 208!
DEC 27 2005 “
Ms. Valerie Defiesta-Ng
Director, Regulatory Affairs
ArthoCare Corporation
680 Vaqueros Avenue
Sunnyvale, California 94085-3523
Re: K053447
Trade/Device Name: ArthoCare® PercD™ SpineWand™
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and
Coagulation device and accessories.
Regulatory Class: If
Product Code: GEL
Dated: December 9, 2005
Received: December 9, 2005
Dear Ms. Defiesta-Ng:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
: for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class II] (PMA),
it may be subject to such additional controls. Existing major regulations affecting your device
can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA
may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

|
Page 2 — Ms. Defiesta-Ng
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your
device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-01 15. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain
, other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/ index.html.
Sincerely yours,
Mark N. Melkerson
Acting Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure

Indications for Use Statement
510(k) Number: KO5344 1
Device Name: ArthroCare® Pere-D™ SpineWand™
Indications for use:
The Perc-D™ SpineWand™ is indicated for ablation, coagulation, and decompression of
disc material to treat symptomatic patients with contained herniated discs.
Prescription Use x AND/OR Over-the-Counter
Use
(Part 21 CFR 801 (21 CFR 807 Subpart —
Subpart D) C)
__(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE) _ ae
a Prwcluty $a NM
(Division Sign-Off)
Division of General, Restors..+.
and Neurological Devices
510(k) Number_Kos 244 F_
x

